Sponsors & CROs
The catchment, the team, the technology, and the track record behind 500+ completed trials.
For three decades, national and international sponsors and CROs have turned to ALSA Research when they need results they can count on. Here's what's behind that reputation.
By the numbers
13M+
Population within a 30-min commute
30+
Years in business
500+
Studies completed
3
Dedicated locations
1 day
Feasibility turnaround
<1 week
Contract turnaround
<1 week
IRB submission
<4 weeks
Study start up
100%
Enrollment performance
95%+
Subject retention
<24 hours
Data entry
0
FDA 483s
Catchment demographics
Our 13M+ accessible population is one of the most diverse in the country — and our sites are located and staffed to enroll it.
Recruitment & retention
01
Accumulated across 30+ years and shared by all three sites — pre-screening starts the day a study is awarded, not the day it activates.
02
Recruitment is a staffed function, not an afterthought — dedicated recruiters work the registry, referrals, and digital channels for every study.
03
AI platforms scale our outreach and pre-screening to match the demands of fast-moving, high-volume studies — and every AI touchpoint is verified by a human recruiter before a patient moves forward.
04
Targeted, HIPAA-conscious social and digital advertising managed in-house, with creative tailored per indication.
The result: 100% enrollment performance and 95%+ subject retention across our portfolio.
Technology & data
CRIO runs all three locations — source data is captured electronically at the point of care, never transcribed from paper.
Visit data is entered and visible within a day, so queries close fast and your data cuts stay current.
Monitors get secure remote access to source — fewer on-site visits, faster verification, and dedicated workstations when they do come.
Regulatory documents are electronic across the network — one centralized team maintains them for all three sites.
We use proprietary AI-based systems internally to help drive quality and compliance across our operations.
Across 30+ years and 500+ studies. Quality is caught internally, not at inspection.
Case studies
Partnering with a Tier 1 sponsor, we achieved 148% of the contracted enrollment target over a period of 4 months.
Supporting a pivotal phase 3 weight loss study, we enrolled 42 subjects and achieved 132% of the contracted enrollment target.
On a critical COVID-19/Flu vaccine program, we achieved 110% of the contracted enrollment target, screening 30 subjects per week to meet tight study timelines.
Facilities
Therapeutic areas of expertise
Indications
Adult and pediatric populations across most of these indications — ask us about yours.
Sponsors We've Worked With
Get in touch
Tell us about your protocol and we'll respond within two business days.
